Stockscreener 앱 받기
1.07
0.93%
-0.01
시장 영업 전:
1.07
전일 마감가:
$1.08
열려 있는:
$1.078
하루 거래량:
48,271
Relative Volume:
0.37
시가총액:
$3.98M
수익:
-
순이익/손실:
$-8.91M
주가수익비율:
-0.0275
EPS:
-38.8702
순현금흐름:
$-8.27M
1주 성능:
-7.76%
1개월 성능:
-14.40%
6개월 성능:
-75.23%
1년 성능:
-90.78%
1일 변동 폭
$1.05
$1.11
1주일 범위
$1.0401
$1.18
52주 변동 폭
$0.9901
$13.36
Revelation Biosciences Inc Stock (REVB) Company Profile
명칭
Revelation Biosciences Inc
전화
650-800-3717
주소
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Compare REVB vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
1.07 | 3.98M | 0 | -8.91M | -8.27M | -38.87 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Revelation Biosciences Inc 주식(REVB)의 최신 뉴스
Revelation Biosciences Inc expected to post a loss of $1.15 a shareEarnings Preview - TradingView
Revelation Biosciences (REVB) CEO has shares sold to cover tax withholding - Stock Titan
Revelation Biosciences (REVB) CFO reports tax-withholding share sale via trust - Stock Titan
Revelation Biosciences (NASDAQ: REVB) asks shareholders to approve wide reverse split - Stock Titan
REVB Revelation Biosciences reports vastly wider Q4 2025 loss than estimates, shares end flat for the trading day.Beat Estimates - Newser
Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development - The Sheboygan Press
REVB Revelation Biosciences posts massive Q4 2025 EPS shortfall on zero revenue, shares remain unchanged.Operational Risk - Cổng thông tin điện tử tỉnh Tây Ninh
REVB (Revelation Biosciences Inc.) posts drastically wider than expected Q4 2025 loss, sending its stock down 4.76% in today’s trading.EBITDA Margin - UBND thành phố Hải Phòng
REVB (Revelation Biosciences Inc.) falls 4.58% today after Q4 2025 EPS misses estimates by a staggering 541.5%. - UBND thành phố Hải Phòng
Aug Setups: Is Revelation Biosciences Inc Equity Warrant showing insider buyingQuarterly Earnings Summary & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Aug Sectors: What is the Moat Score of Revelation Biosciences Inc2026 Momentum Check & Advanced Technical Analysis Signals - baoquankhu1.vn
Forecast Cut: Can Revelation Biosciences Inc Equity Warrant grow without dilution2026 Catalysts & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Aug Decliners: What are the risks of holding Revelation Biosciences IncQuarterly Profit Report & Daily Technical Forecast Reports - baoquankhu1.vn
REVB Technical Analysis & Stock Price Forecast - Intellectia AI
Fed Meeting: Will Revelation Biosciences Inc Equity Warrant benefit from green energy policiesEarnings Summary Report & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Support Test: What is Revelation Biosciences Inc Equity Warrants valuation compared to sector2026 Top Decliners & Community Shared Stock Ideas - baoquankhu1.vn
Stock Market Recap: Can Revelation Biosciences Inc keep up with sector leadersWeekly Profit Analysis & Smart Swing Trading Alerts - baoquankhu1.vn
US Market Wrap: Is Revelation Biosciences Inc Equity Warrant showing insider buyingWeekly Trade Analysis & Real-Time Price Movement Reports - baoquankhu1.vn
Revelation Biosciences forms advisory board for AKI trial By Investing.com - Investing.com Australia
Chart Watch: Does Revelation Biosciences Inc Equity Warrant stock benefit from AI growthDip Buying & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Revelation Biosciences Forms Acute Kidney Injury Advisory Board - National Today
Revelation Biosciences forms advisory board for AKI trial - Investing.com
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board - ACCESS Newswire
Kidney injury trial draws 5 specialists to guide Revelation study - Stock Titan
REVB SEC FilingsRevelation Biosciences 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Wrap: Will Revelation Biosciences Inc Equity Warrant benefit from green energy policies2026 Trade Ideas & Stepwise Trade Execution Plans - baoquankhu1.vn
History Review: What is Revelation Biosciences Inc Equity Warrants valuation compared to sectorWeekly Investment Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Short Squeeze: Is Revelation Biosciences Inc Equity Warrant backed by strong institutional buying2026 Momentum & Stepwise Trade Signal Implementation - baoquankhu1.vn
Returns Recap: Is Revelation Biosciences Inc Equity Warrant stock influenced by commodity prices2026 Short Interest & Weekly Breakout Watchlists - baoquankhu1.vn
Sectors Review: What are the risks of holding Revelation Biosciences IncTrade Exit Summary & Smart Investment Allocation Tips - baoquankhu1.vn
Aug Closing: Can Revelation Biosciences Inc Equity Warrant grow without dilution2026 Momentum Check & Community Shared Stock Ideas - baoquankhu1.vn
Revelation Biosciences Presents Positive Data from Prime Clinical Study - National Today
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study - ACCESS Newswire
A single Gemini dose restored immune response for 7 days in CKD study - Stock Titan
Fund Flows: How does Revelation Biosciences Inc Equity Warrant compare to its peersTrade Volume Summary & Smart Swing Trading Alerts - baoquankhu1.vn
Can Revelation Biosciences (REVB) Stock Reach New Highs | Price at $1.19, Up 1.70%Momentum Picks - Newser
REVB Should I Buy - Intellectia AI
Growth Report: How does Revelation Biosciences Inc Equity Warrant compare to its peersQuarterly Portfolio Summary & Safe Entry Momentum Stock Tips - baoquankhu1.vn
REMINDER: Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference - thenewstribune.com
If You Invested $1,000 in Revelation Biosciences (REVB) - Stock Titan
Aug Momentum: Is Revelation Biosciences Inc Equity Warrant showing insider buyingPortfolio Update Summary & Community Trade Idea Sharing - baoquankhu1.vn
Revelation Biosciences, Inc.: Fundamental Analysis and Financial Ratings | | US76135L7055 - marketscreener.com
Swing Trade: What makes Revelation Biosciences Inc stock attractive today2026 Earnings Surprises & Accurate Technical Buy Alerts - baoquankhu1.vn
Aug Patterns: How does Revelation Biosciences Inc Equity Warrant compare to its peersRate Hike & Daily Market Momentum Tracking - baoquankhu1.vn
Revelation Biosciences stockholders approve warrant issuance beyond Nasdaq cap By Investing.com - Investing.com India
Revelation Biosciences, Inc. 8-K SEC Filing March 2026 – Company Information, Address, and Security Details - Minichart
Revelation Biosciences stockholders approve warrant issuance beyond Nasdaq cap - Investing.com
Revelation Biosciences (NASDAQ: REVB) clears Class J warrant share issuance - Stock Titan
Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference - ACCESS Newswire
Revelation Biosciences Inc (REVB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):